Monthly production capacity of Covishield projected to increase to 120 million doses, Covaxin to 58 million doses: Minister

The Department of Biotechnology under the Ministry of Science and Technology has launched 'Mission COVID Suraksha- the Indian COVID-19 Vaccine Development Mission' to support the production of vaccines.

The monthly production capacity of Covishield is projected to be increased to more than 120 million doses and of Covaxin to around 58 million doses by December, the government told Rajya Sabha on Tuesday, citing information from the COVID-19 vaccine manufacturers. Union Health Minister Mansukh Mandaviya was responding to a questionon the current capacity to manufacture Covaxin and Covishield in the country, and the expected capacity going forward from August to December 2021. "As communicated by the manufacturers, the monthly vaccine production capacity of Covishield is projected to be increased from 110 million doses per month to more than 120 million doses per month and the production capacity of Covaxin is projected to be increased from 25 million doses per month to around 58 million doses per month," the minister said in a written reply.